Kong Q

No ORCID on file · 1 paper in corpus
2026
Frontiers in oncology ·doi:10.3389/fonc.2026.1745519

Tumor heterogeneity is a core challenge in gynecologic oncology, driving therapeutic resistance and limiting the efficacy of single-point biopsies. Artificial intelligence (AI) and radiomics are emerging as a "digital biopsy" to non-invasiv…